| Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder S Jazayeri, M Tehrani-Doost, SA Keshavarz, M Hosseini, A Djazayery, ... Australian and New Zealand Journal of Psychiatry 42 (3), 192-198, 2008 | 314 | 2008 |
| The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers AA Mohammadi, S Jazayeri, K Khosravi-Darani, Z Solati, ... Nutritional neuroscience 19 (9), 387-395, 2016 | 296 | 2016 |
| Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder N Khoraminya, M Tehrani-Doost, S Jazayeri, A Hosseini, A Djazayery Australian & New Zealand Journal of Psychiatry 47 (3), 271-275, 2013 | 194 | 2013 |
| Prevalence of obsessive-compulsive disorder in Iran MR Mohammadi, A Ghanizadeh, M Rahgozar, AA Noorbala, H Davidian, ... BMC psychiatry 4 (1), 1-8, 2004 | 148 | 2004 |
| Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder S Jazayeri, SA Keshavarz, M Tehrani-Doost, M Djalali, M Hosseini, ... Psychiatry research 178 (1), 112-115, 2010 | 133 | 2010 |
| subclinical hypothyroidism in pregnancy: Intellectual development of offspring F behrooz, H.G., Tohidi, M., Mehrabi, Y., Behrooz, E.G., Tehranidoost, M., Azizi Thyroid 21 (10), 1143-1147, 2011 | 120 | 2011 |
| Zinc monotherapy increases serum brain-derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized … Z Solati, S Jazayeri, M Tehrani-Doost, S Mahmoodianfard, MR Gohari Nutritional neuroscience 18 (4), 162-168, 2015 | 110 | 2015 |
| Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double‐blind, randomized, placebo‐controlled trial S Akhondzadeh, MR Milajerdi, H Amini, M Tehrani‐Doost Bipolar disorders 8 (5p1), 485-489, 2006 | 97 | 2006 |
| The reliability and validity of kiddie‐schedule for affective disorders and schizophrenia‐present and life‐time version‐Persian version Z Shahrivar, M Kousha, S Moallemi, M Tehrani‐Doost, J Alaghband‐Rad Child and Adolescent Mental Health 15 (2), 97-102, 2010 | 78 | 2010 |
| Normative data and psychometric properties of the child behavior checklist and teacher rating form in an Iranian community sample M Tehrani-Doost, Z Shahrivar, B Pakbaz, A Rezaie, F Ahmadi Iranian journal of pediatrics 21 (3), 331, 2011 | 72 | 2011 |
| Normative data and psychometric properties of the parent and teacher versions of the strengths and difficulties questionnaire (SDQ) in an Iranian community sample Z Shahrivar, M Tehrani-Doost, B Pakbaz, A Rezaie, F Ahmadi Journal of research in medical sciences: the official journal of Isfahan …, 2009 | 69 | 2009 |
| Effect of vitamin D supplementation as adjunctive therapy to methylphenidate on ADHD symptoms: A randomized, double blind, placebo-controlled trial N Mohammadpour, S Jazayeri, M Tehrani-Doost, M Djalali, M Hosseini, ... Nutritional neuroscience 21 (3), 202-209, 2018 | 68 | 2018 |
| Cyproheptadine in the treatment of autistic disorder: a double‐blind placebo‐controlled trial S Akhondzadeh, S Erfani, MR Mohammadi, M Tehrani‐Doost, H Amini, ... Journal of clinical pharmacy and therapeutics 29 (2), 145-150, 2004 | 64 | 2004 |
| Toxoplasma infection in schizophrenia patients: a comparative study with control group H Alipour, A., Shojaee, S., Mohebali, M., Tehranidoost, M., Abdi Masoleh, F ... iranian Journal of Parasitology 6 (2), 31-37, 2011 | 57 | 2011 |
| Effects of probiotics on biomarkers of oxidative stress and inflammatory factors in petrochemical workers: a randomized, double-blind, placebo-controlled trial AA Mohammadi, S Jazayeri, K Khosravi-Darani, Z Solati, ... International journal of preventive medicine 6, 2015 | 56 | 2015 |
| Using non-linear features of EEG for ADHD/normal participants’ classification F Ghassemi, M Hassan_Moradi, M Tehrani-Doost, V Abootalebi Procedia-Social and Behavioral Sciences 32, 148-152, 2012 | 53 | 2012 |
| selegiline in comparison with methylphenidate in attention deficit/hyperactivity disorder children and adolescents in a double-blind randomized clinical trial H mohammadi, M.R., Ghanizadeh, A., Alaghband-Rad, j., Tehranidoost,M ... Journal of Child and Adolescent Psychopharmacology 14 (3), 418-423, 2004 | 50 | 2004 |
| Effectiveness of a low-intensity home-based aftercare for patients with severe mental disorders: a 12-month randomizes controlled study m. sharifi, V., Tehranidoost, M., Yunesian, M., Amini, H., mohammadi, M ... community Mental Health 48 (6), 766-770, 2012 | 48* | 2012 |
| Executive dysfunction in treated phenylketonuric patients B Azadi, A Seddigh, M Tehrani-Doost, J Alaghband-Rad, MR Ashrafi European child & adolescent psychiatry 18, 360-368, 2009 | 45 | 2009 |
| Prevalence of psychiatric disorders amongst adolescents in Tehran Z Shahrivar, J Mahmoodi, A Alavi, MR Mohammadi, M Tehranidoost, ... Iranian Journal of Psychiatry 3 (3), 100-104, 2008 | 44 | 2008 |
Homayoun AminiProfessor of Psychiatry, Roozbeh Hospital, Tehran University of Medical SciencesVerified email at tums.ac.ir
